Combined laser and ozone therapy for onychomycosis in an in vitro and ex vivo model
- PMID: 34191858
- PMCID: PMC8244860
- DOI: 10.1371/journal.pone.0253979
Combined laser and ozone therapy for onychomycosis in an in vitro and ex vivo model
Abstract
In order to develop a fast combined method for onychomycosis treatment using an in vitro and an ex vivo models, a combination of two dual-diode lasers at 405 nm and 639 nm wavelengths, in a continuous manner, together with different ozone concentrations (until 80 ppm), was used for performing the experiments on fungal strains growing on PDA agar medium or on pig's hooves samples. In the in vitro model experiments, with 30 min combined treatment, all species are inhibited at 40 ppm ozone concentration, except S. brevicaulis, which didn't show an inhibition in comparison with only ozone treatment. In the ex vivo model experiments, with the same duration and ozone concentration, A. chrysogenum and E. floccosum showed total inhibition; T. mentagrophytes and T. rubrum showed a 75% growth inhibition; M. canis showed a delay in sporulation; and S. brevicaulis and A. terreus did not show growth inhibition. This combined laser and ozone treatment may be developed as a fast therapy for human onychomycosis, as a potential alternative to the use of antifungal drugs with potential side effects and long duration treatments.
Conflict of interest statement
The authors have read the journal’s policy and have the following competing interests: IVF is paid employee of Termosalud SL. There are no patents, products in development or marketed products associated with this research to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials. All other authors declare that they have no competing interests.
Figures







Similar articles
-
Detection and differentiation of causative organisms of onychomycosis in an ex vivo nail model by means of Raman spectroscopy.J Eur Acad Dermatol Venereol. 2014 Nov;28(11):1492-9. doi: 10.1111/jdv.12324. Epub 2013 Nov 28. J Eur Acad Dermatol Venereol. 2014. PMID: 24286616
-
Sanitization of contaminated footwear from onychomycosis patients using ozone gas: a novel adjunct therapy for treating onychomycosis and tinea pedis?J Cutan Med Surg. 2013 Jul-Aug;17(4):243-9. doi: 10.2310/7750.2012.12068. J Cutan Med Surg. 2013. PMID: 23815956
-
Low-voltage direct current as a fungicidal agent for treating onychomycosis.J Am Podiatr Med Assoc. 2004 Nov-Dec;94(6):565-72. doi: 10.7547/0940565. J Am Podiatr Med Assoc. 2004. PMID: 15547124
-
New treatment options for onychomycosis.J Cosmet Laser Ther. 2014 Dec;16(6):306-10. doi: 10.3109/14764172.2014.957213. Epub 2014 Sep 29. J Cosmet Laser Ther. 2014. PMID: 25148411 Review.
-
A review of the mechanism of action of lasers and photodynamic therapy for onychomycosis.Lasers Med Sci. 2017 Feb;32(2):469-474. doi: 10.1007/s10103-016-2110-9. Epub 2016 Nov 24. Lasers Med Sci. 2017. PMID: 27885523 Review.
Cited by
-
Laser Treatment in Nail Disorders: A Comprehensive Review.Indian Dermatol Online J. 2024 Dec 26;16(1):59-71. doi: 10.4103/idoj.idoj_776_24. eCollection 2025 Jan-Feb. Indian Dermatol Online J. 2024. PMID: 39850697 Free PMC article.
-
Ozone therapy for skin diseases: Cellular and molecular mechanisms.Int Wound J. 2023 Aug;20(6):2376-2385. doi: 10.1111/iwj.14060. Epub 2022 Dec 16. Int Wound J. 2023. PMID: 36527235 Free PMC article. Review.
References
-
- Shokoohi GR, Ansari S, Abolghazi A, Gramishoar M, Nouripour-Sisakht S, Mirhendi H, et al.. The first case of fingernail onychomycosis due to Neoscytalidium novaehollandiae, molecular identification and antifungal susceptibility. J Mycol Med. 2019; 100920. doi: 10.1016/j.mycmed.2019.100920 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical